354
Castle Biosciences Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
292
FY23:
296
FY24:
360
FY25:
361
(positive)
Change from FY21 to FY25
millions USD
FY21:
109
FY22:
155
FY23:
158
FY24:
171
FY25:
217
Total assets
Change from FY21 to FY25
millions USD
FY21:
463
FY22:
447
FY23:
453
FY24:
531
FY25:
579
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
24.9
FY22:
36.1
FY23:
47.7
FY24:
49.4
FY25:
68.7
(negative)
Change from FY21 to FY25
millions USD
FY21:
25.9
FY22:
12.1
FY23:
14.4
FY24:
26.0
FY25:
39.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
412
FY22:
399
FY23:
391
FY24:
456
FY25:
471
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
463
FY22:
447
FY23:
453
FY24:
531
FY25:
579
All amounts in millions USD